Search for other papers by Nancy J Olsen in
Google Scholar
PubMed
Search for other papers by Ann L Benko in
Google Scholar
PubMed
Search for other papers by William J Kovacs in
Google Scholar
PubMed
hormonal excess or deficiency states. Inherited variation in the androgen receptor ( AR ) gene affects androgen action. Deleterious mutations in AR can result in syndromes ranging from mild abnormalities to total failure of normal male phenotypic
Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain
Search for other papers by Susana Pastor in
Google Scholar
PubMed
Search for other papers by Abdelmounaim Akdi in
Google Scholar
PubMed
Search for other papers by Eddy R González in
Google Scholar
PubMed
Search for other papers by Juan Castell in
Google Scholar
PubMed
Search for other papers by Josefina Biarnés in
Google Scholar
PubMed
Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain
Search for other papers by Ricard Marcos in
Google Scholar
PubMed
Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain
Search for other papers by Antonia Velázquez in
Google Scholar
PubMed
, 12) . Polymorphic variations in the FOXE1 and NKX2-1 genes, both involved in thyroid function and development of the thyroid gland, have also been reported to be associated with the risk of thyroid cancer (10, 13, 14) . Furthermore, common
Search for other papers by Malgorzata Oczko-Wojciechowska in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Tomasz Gawlik in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Jolanta Krajewska in
Google Scholar
PubMed
. Next generation sequencing ( NGS ) in MTC Currently, NGS is routinely used in molecular diagnostics of the whole exons of one gene (e.g., the RET gene mutations) or a few selected genes involved in developing the disease. Surprisingly, the first
Search for other papers by Angela Köninger in
Google Scholar
PubMed
Search for other papers by Philippos Edimiris in
Google Scholar
PubMed
Search for other papers by Laura Koch in
Google Scholar
PubMed
Search for other papers by Antje Enekwe in
Google Scholar
PubMed
Search for other papers by Claudia Lamina in
Google Scholar
PubMed
Search for other papers by Sabine Kasimir-Bauer in
Google Scholar
PubMed
Search for other papers by Rainer Kimmig in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, Division of Genetic Epidemiology, Vitateq Biotechnology GmbH, University of Duisburg-Essen, D-45122 Essen, Germany
Search for other papers by Hans Dieplinger in
Google Scholar
PubMed
confirmed, when two of the following three diagnostic criteria are present: i) hyperandrogenism, ii) polycystic ovaries with ≥12 sonographically measured small follicles with a diameter between 2 and 9 mm and/or an ovarian volume >10 ml, and iii) oligo- or
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Mark J C van Treijen in
Google Scholar
PubMed
Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Catharina M Korse in
Google Scholar
PubMed
Department of Gastroenterology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Wieke H Verbeek in
Google Scholar
PubMed
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Margot E T Tesselaar in
Google Scholar
PubMed
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
increased over the past decades, most likely because of improvements in diagnostic techniques and disease awareness ( 1 , 2 , 3 ). GEPNETs are grouped based on their shared neuroendocrine markers and proteins, such as chromogranin and synaptophysin, but
Search for other papers by Irfan Vardarli in
Google Scholar
PubMed
Search for other papers by Manuel Weber in
Google Scholar
PubMed
Search for other papers by Frank Weidemann in
Google Scholar
PubMed
Search for other papers by Dagmar Führer in
Google Scholar
PubMed
Search for other papers by Ken Herrmann in
Google Scholar
PubMed
Search for other papers by Rainer Görges in
Google Scholar
PubMed
identified in their last search for inclusion. A meta-analysis on this subject has not been published until now. Therefore, we performed this meta-analysis to elucidate the diagnostic accuracy of routine serum calcitonin measurement for detection of MTC in
Search for other papers by Elena Pardi in
Google Scholar
PubMed
Search for other papers by Stefano Mariotti in
Google Scholar
PubMed
Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed
Search for other papers by Katiuscia Benfini in
Google Scholar
PubMed
Search for other papers by Simona Borsari in
Google Scholar
PubMed
Search for other papers by Federica Saponaro in
Google Scholar
PubMed
Search for other papers by Liborio Torregrossa in
Google Scholar
PubMed
Search for other papers by Antonello Cappai in
Google Scholar
PubMed
Search for other papers by Chiara Satta in
Google Scholar
PubMed
Search for other papers by Marco Mastinu in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Filomena Cetani in
Google Scholar
PubMed
gene – the main molecular defect causing the MEN1 syndrome – have been detected in about 70–80% and 30% of patients with familial and sporadic MEN1 respectively (3) . The percentage in familial MEN1 rises to 90% if a search for large germline deletions
Search for other papers by Zi-Di Xu in
Google Scholar
PubMed
Search for other papers by Wei Zhang in
Google Scholar
PubMed
Search for other papers by Min Liu in
Google Scholar
PubMed
Search for other papers by Huan-Min Wang in
Google Scholar
PubMed
Search for other papers by Pei-Pei Hui in
Google Scholar
PubMed
Search for other papers by Xue-Jun Liang in
Google Scholar
PubMed
Search for other papers by Jie Yan in
Google Scholar
PubMed
Search for other papers by Yu-Jun Wu in
Google Scholar
PubMed
Search for other papers by Yan-Mei Sang in
Google Scholar
PubMed
Search for other papers by Cheng Zhu in
Google Scholar
PubMed
Search for other papers by Gui-Chen Ni in
Google Scholar
PubMed
Congenital hyperinsulinism (CHI) is a kind of genetically heterogeneous disease, in which intractable, persistent hypoglycemia is induced by excessive insulin secretion and increased serum insulin concentration ( 1 ). To date, 14 genes ( ABCC8
Search for other papers by Filomena Cetani in
Google Scholar
PubMed
Search for other papers by Chiara Banti in
Google Scholar
PubMed
Search for other papers by Elena Pardi in
Google Scholar
PubMed
Search for other papers by Simona Borsari in
Google Scholar
PubMed
Search for other papers by Paolo Viacava in
Google Scholar
PubMed
Search for other papers by Paolo Miccoli in
Google Scholar
PubMed
Search for other papers by Liborio Torregrossa in
Google Scholar
PubMed
Search for other papers by Fulvio Basolo in
Google Scholar
PubMed
Search for other papers by Maria Rosa Pelizzo in
Google Scholar
PubMed
Search for other papers by Massimo Rugge in
Google Scholar
PubMed
Search for other papers by Gianmaria Pennelli in
Google Scholar
PubMed
Search for other papers by Guido Gasparri in
Google Scholar
PubMed
Search for other papers by Mauro Papotti in
Google Scholar
PubMed
Search for other papers by Marco Volante in
Google Scholar
PubMed
Search for other papers by Edda Vignali in
Google Scholar
PubMed
Search for other papers by Federica Saponaro in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
reported by Haven et al . (18) . Following the demonstration of CDC73 mutations in PC, several studies were carried out to evaluate whether immunostaining of parafibromin, the gene product, might have some diagnostic utility. Diffuse or focal loss of
Search for other papers by Meihua Jin in
Google Scholar
PubMed
Search for other papers by Woo Kyung Lee in
Google Scholar
PubMed
Search for other papers by Mi-Hyeon You in
Google Scholar
PubMed
Search for other papers by Ahreum Jang in
Google Scholar
PubMed
Search for other papers by Sheue-yann Cheng in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Yu-Mi Lee in
Google Scholar
PubMed
expression. Analysis of TCGA data Transcriptomes and matched clinicopathological data from thyroid cancers deposited in The Cancer Genome Atlas (TCGA-THCA) were used to explore the biological and clinical significance of the SHMT2 gene. To do this